CAPTIA CMV-G
510(k) K896194
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK896194 | Date6 Mar 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Captia(R) Cmv-G
- 510(k) Number
- FDA Product Code
- LFZ
- FDA applicant
- Mercia Diagnostics , Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3175
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The CAPTIA CMV-G is an Enzyme Linked Immunoabsorbent Assay (ELISA) for the detection of cytomegalovirus (CMV) antibodies. This in vitro diagnostic device quantifies immunoglobulin G (IgG) antibodies to CMV, aiding in the serological diagnosis of CMV infection or immunity. It is classified under microbiological assays and designed for laboratory use to support clinical assessments of CMV exposure or disease status.
This device is supplied as a single-use reagent kit for professional laboratory use, requiring no special storage conditions beyond refrigeration. It is intended for use in clinical microbiology settings and has been granted FDA 510(k) clearance under product code LFZ, adhering to 21 CFR 866.3175. The assay is not MRI-compatible and must be handled in accordance with standard laboratory practices for immunoassays, ensuring sterility and accuracy in diagnostic results.
Other devices from Mercia Diagnostics, Ltd.
Questions
AI-generated answers, 1 Oct 2026
What is the CAPTIA CMV-G ELISA used for?
The CAPTIA CMV-G ELISA is an in vitro diagnostic device designed to quantify immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV). It aids in the serological diagnosis of CMV infection or immunity by providing quantitative results, helping clinicians assess a patient’s exposure or disease status related to CMV.
How is the CAPTIA CMV-G ELISA supplied and stored?
The CAPTIA CMV-G ELISA is supplied as a single-use reagent kit intended for professional laboratory use. It requires standard refrigeration for storage, with no additional specialized conditions needed. Always follow standard laboratory practices to maintain sterility and accuracy.
Is the CAPTIA CMV-G ELISA intended for single-use or reuse?
The CAPTIA CMV-G ELISA is explicitly designed for single-use only. This ensures sterility, consistency, and reliability in diagnostic results, as reuse could compromise the integrity of the assay and introduce contamination risks.
What are the key specifications or regulatory details for this device?
The CAPTIA CMV-G ELISA has been granted FDA 510(k) clearance under product code LFZ, adhering to 21 CFR 866.3175. It is classified as an Enzyme Linked Immunoabsorbent Assay (ELISA) and falls under the microbiological assays category for clinical microbiology use. The device is not MRI-compatible and must be handled according to standard immunoassay laboratory protocols.
Can this device be used outside of a clinical microbiology lab?
No, the CAPTIA CMV-G ELISA is specifically designed for laboratory use in clinical microbiology settings. Its intended use relies on controlled conditions, trained personnel, and proper equipment to ensure accurate and reliable diagnostic results for CMV antibody quantification.